Company intelligence / Profile preview

Emtelligent

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Emtelligent’s platform demonstrates high (>95%) accuracy in NLP-driven extraction and structuring of real-world clinical data, enabling improved safety, efficiency, and analytics for diverse healthcare stakeholders including payers, providers, and pharma companies. Major deployments include building clinical data marts for US payers and enabling advanced medical review workflows.

Modalities: Non-pharmacological therapy
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Deployments with major US payers (unnamed)radiology groupshospitalshealth systemspharmaceutical companies

Beyond the preview

Go deeper on Emtelligent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emtelligent.

Explore the full profile